AAV is an autoimmune disorder in which the immune system mistakenly attacks blood vessels, which leads to inflammation and causes damage to the kidneys, lungs, and nervous system.
ANCA-Associated Vasculitis
Hightower Clinical conducted studies to advance care for ANCA-Associated Vasculitis by evaluating the safety and effectiveness of a new investigational therapy.
About ANCA-Associated Vasculitis Clinical Study
ANCA-associated vasculitis is a rare autoimmune disease where the body’s immune system mistakenly attacks blood vessels, causing inflammation and damage to organs like the kidneys, lungs, and nerves.
Hightower Clinical previously conducted a clinical study to explore new ways to manage this condition. The research focused on evaluating the safety and potential benefits of an investigational therapy to help improve future treatment options for patients living with AAV.
Current Status
Not Recruiting
Study Count
1
Study Information
ANCA-Associated Vasculitis
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| ANCA-Associated Vasculitis | 20220159 | Amgen |
Frequently Asked Questions
What are the early signs of ANCA Vasculitis?
Early signs may include fatigue, fever, unexplained weight loss, joint pain, shortness of breath, and kidney problems. Symptoms vary depending on which organs are affected.
Is ANCA Vasculitis fatal?
If left untreated, AAV can lead to serious organ damage. With proper diagnosis and treatment, many patients can manage the disease and improve their quality of life.
Why should I participate in the ANCA-Associated Vasculitis study?
Participating helps advance research, improves understanding of the disease, and contributes to the development of better treatment options for people living with AAV.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.